Effects of proton pump inhibitors on osseointegration of oral implants

doi:10.12337/zgkqzzxzz.2024.06.014

Abstract

Abstract: Proton pump inhibitors (PPIs) are commonly used drugs to treat conditions related to abnormal gastric acid secretion. They have been found to affect bone metabolism, which can impact bone healing. There is ongoing research on the potential impact of PPIs on the success of implant surgery. Current studies suggest that PPIs may have a limited effect on implant failure rates. Therefore, caution should be exercised when considering treatment plans for patients taking PPIs, and discontinuing PPIs solely to improve implant success rates is not recommended.

Key words: Proton pump inhibitors, Osseointegration, Dental implants

Wang Mingyang, Huang Haitao. Effects of proton pump inhibitors on osseointegration of oral implants[J]. Chinese Journal of Oral Implantology, 2024, 29(3): 277-283.

References

[1] Freedberg DE, Kim LS, Yang YX.The risks and benefits of long-term use of proton pump inhibitors: expert review and best practice advice from the american gastroenterological association[J]. Gastroenterology, 2017,152(4):706-715. DOI: 10.1053/j.gastro.2017.01.031.
[2] Khan S, Mohammad A, O'Rourke KP. An audit of the frequency of proton pump inhibitor (PPI) prescription in rheumatoid arthritis (RA) patients taking non-steroidal anti-inflammatory drugs (NSAIDs)[J]. Ir J Med Sci, 2014,183(4):685-686. DOI: 10.1007/s11845-014-1152-x.
[3] 中华人民共和国国家卫生健康委员会.质子泵抑制剂临床应用指导原则(2020年版)[J]. 中国实用乡村医生杂志, 2021, 28(1): 1-9.
[4] Jemt T.Single-implant survival: more than 30 years of clinical experience[J]. Int J Prosthodont, 2016,29(6):551-558. DOI: 10.11607/ijp.4892.
[5] Guglielmotti MB, Olmedo DG, Cabrini RL.Research on implants and osseointegration[J]. Periodontol 2000, 2019,79(1):178-189. DOI: 10.1111/prd.12254.
[6] Aghaloo T, Pi-Anfruns J, Moshaverinia A, et al.The effects of systemic diseases and medications on implant osseointegration: a systematic review[J]. Int J Oral Maxillofac Implants, 2019,34:s35-s49. DOI: 10.11607/jomi.19suppl.g3.
[7] 于丽媛, 龚晓健, 王永庆. 长期使用质子泵抑制剂致骨质疏松的研究进展[J].药学与临床研究,2017,25(3):237-242.
[8] 国家食品药品监督管理总局提醒警惕质子泵抑制剂的骨折、低镁血症风险以及与氯吡格雷的相互作用[J].中国药房,2013,(25):2400.
[9] Chawla BK, Cohen RE, Stellrecht EM, et al.The influence of proton pump inhibitors on tissue attachment around teeth and dental implants: a scoping review[J]. Clin Exp Dent Res, 2022,8(5):1045-1058. DOI: 10.1002/cre2.616.
[10] Engevik AC, Kaji I, Goldenring JR.The physiology of the gastric parietal cell[J]. Physiol Rev, 2020,100(2):573-602. DOI: 10.1152/physrev.00016.2019.
[11] Savarino V, Di Mario F, Scarpignato C.Proton pump inhibitors in GORD an overview of their pharmacology, efficacy and safety[J]. Pharmacol Res, 2009,59(3):135-153. DOI: 10.1016/j.phrs.2008.09.016.
[12] Strand DS, Kim D, Peura DA.25 Years of proton pump inhibitors: a comprehensive review[J]. Gut Liver, 2017,11(1):27-37. DOI: 10.5009/gnl15502.
[13] Besancon M, Simon A, Sachs G, et al.Sites of reaction of the gastric H,K-ATPase with extracytoplasmic thiol reagents[J]. J Biol Chem, 1997,272(36):22438-22446. DOI: 10.1074/jbc.272.36.22438.
[14] Ito T, Jensen RT.Association of long-term proton pump inhibitor therapy with bone fractures and effects on absorption of calcium, vitamin B₁₂, iron, and magnesium[J]. Curr Gastroenterol Rep, 2010,12(6):448-457. DOI: 10.1007/s11894-010-0141-0.
[15] Hess MW, de Baaij JH, Gommers LM, et al. Dietary inulin fibers prevent proton-pump inhibitor (PPI)-induced hypocalcemia in mice[J]. PLoS One, 2015,10(9):e0138881. DOI: 10.1371/journal.pone.0138881.
[16] Graziani G, Como G, Badalamenti S, et al.Effect of gastric acid secretion on intestinal phosphate and calcium absorption in normal subjects[J]. Nephrol Dial Transplant, 1995,10(8):1376-1380.
[17] Wright MJ, Sullivan RR, Gaffney-Stomberg E, et al.Inhibiting gastric acid production does not affect intestinal calcium absorption in young, healthy individuals: a randomized, crossover, controlled clinical trial[J]. J Bone Miner Res, 2010,25(10):2205-2211. DOI: 10.1002/jbmr.108.
[18] Datta HK, Ng WF, Walker JA, et al.The cell biology of bone metabolism[J]. J Clin Pathol, 2008,61(5):577-587. DOI: 10.1136/jcp.2007.048868.
[19] Costa-Rodrigues J, Reis S, Teixeira S, et al.Dose-dependent inhibitory effects of proton pump inhibitors on human osteoclastic and osteoblastic cell activity[J]. FEBS J, 2013,280(20):5052-5064. DOI: 10.1111/febs.12478.
[20] Ngamruengphong S, Leontiadis GI, Radhi S, et al. Proton pump inhibitors and risk of fracture: a systematic review and meta-analysis of observational studies[J]. Am J Gastroenterol, 2011,106(7):1209-1218; quiz 1219. DOI: 10.1038/ajg.2011.113.
[21] Farina C, Gagliardi S.Selective inhibition of osteoclast vacuolar H(+)-ATPase[J]. Curr Pharm Des, 2002,8(23):2033-2048. DOI: 10.2174/1381612023393369.
[22] Delomenède M, Buchet R, Mebarek S.Lansoprazole is an uncompetitive inhibitor of tissue-nonspecific alkaline phosphatase[J]. Acta Biochim Pol, 2009,56(2):301-305.
[23] Pohl D, Fox M, Fried M, et al.Do we need gastric acid?[J]. Digestion, 2008,77(3-4):184-197. DOI: 10.1159/000142726.
[24] Termanini B, Gibril F, Sutliff VE, et al.Effect of long-term gastric acid suppressive therapy on serum vitamin B₁₂ levels in patients with Zollinger-Ellison syndrome[J]. Am J Med, 1998,104(5):422-430. DOI: 10.1016/s0002-9343(98)00087-4.
[25] Miller JW.Proton pump inhibitors, H₂-receptor antagonists, metformin, and vitamin B₁₂ deficiency: clinical implications[J]. Adv Nutr, 2018,9(4):S511-S518. DOI: 10.1093/advances/nmy023.
[26] McLean RR, Jacques PF, Selhub J, et al. Plasma B vitamins, homocysteine, and their relation with bone loss and hip fracture in elderly men and women[J]. J Clin Endocrinol Metab, 2008,93(6):2206-2212. DOI: 10.1210/jc.2007-2710.
[27] Roman-Garcia P, Quiros-Gonzalez I, Mottram L, et al.Vitamin B₁₂-dependent taurine synthesis regulates growth and bone mass[J]. J Clin Invest, 2014,124(7):2988-3002. DOI: 10.1172/JCI72606.
[28] Dai Z, Koh WP.B-vitamins and bone health--a review of the current evidence[J]. Nutrients, 2015,7(5):3322-3346. DOI: 10.3390/nu7053322.
[29] Kim GS, Kim CH, Park JY, et al.Effects of vitamin B₁₂ on cell proliferation and cellular alkaline phosphatase activity in human bone marrow stromal osteoprogenitor cells and UMR106 osteoblastic cells[J]. Metabolism, 1996,45(12):1443-1446. DOI: 10.1016/s0026-0495(96)90171-7.
[30] Bailey RL, van Wijngaarden JP. The role of B-vitamins in bone health and disease in older adults[J]. Curr Osteoporos Rep, 2015,13(4):256-261. DOI: 10.1007/s11914-015-0273-0.
[31] Al Subaie A, Emami E, Tamimi I, et al.Systemic administration of omeprazole interferes with bone healing and implant osseointegration: an in vivo study on rat tibiae[J]. J Clin Periodontol, 2016,43(2):193-203. DOI: 10.1111/jcpe.12506.
[32] Kanounisabet N, Mogharehabed A, Torabinia N, et al.Effect of systemic administration of omeprazole on osseointegration around titanium dental implants: a histomorphometric study in dogs[J]. Dent Res J (Isfahan), 2021,18:43.
[33] Tekin S, Dundar S, Demirci F, et al.Biomechanical and biochemical evaluation of the effect of systemic application of omeprazole on the osseointegration of titanium implants[J]. Int J Implant Dent, 2021,7(1):27. DOI: 10.1186/s40729-021-00310-5.
[34] Berglundh T, Persson L, Klinge B. A systematic review of the incidence of biological and technical complications in implant dentistry reported in prospective longitudinal studies of at least 5 years[J]. J Clin Periodontol, 2002,29(Suppl 3):197-212; Discussion 232-233. DOI: 10.1034/j.1600-051x.29.s3.12.x.
[35] Altay MA, Sindel A, Özalp Ö, et al.Proton pump inhibitor intake negatively affects the osseointegration of dental implants: a retrospective study[J]. J Korean Assoc Oral Maxillofac Surg, 2019,45(3):135-140. DOI: 10.5125/jkaoms.2019.45.3.135.
[36] Chrcanovic BR, Kisch J, Albrektsson T, et al.Intake of proton pump inhibitors Is associated with an increased risk of dental implant failure[J]. Int J Oral Maxillofac Implants, 2017,32(5):1097-1102. DOI: 10.11607/jomi.5662.
[37] Masri D, Retzkin N, Luís Scombatti de Souza S, et al. The effect of proton pump inhibitors on early implant failure a retrospective cohort study[J]. Medicina (Kaunas), 2023,59(2):402. DOI: 10.3390/medicina59020402.
[38] Rogoszinski T, Dazen C, Rekawek P, et al.Are proton pump inhibitors associated with implant failure and peri-implantitis?[J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2022,133(1):15-20. DOI: 10.1016/j.oooo.2021.05.002.
[39] Ursomanno BL, Cohen RE, Levine MJ, et al.Effect of proton pump inhibitors on bone loss at dental implants[J]. Int J Oral Maxillofac Implants, 2020,35(1):130-134. DOI: 10.11607/jomi.7800.
[40] Wu X, Al-Abedalla K, Abi-Nader S, et al.Proton pump inhibitors and the risk of osseointegrated dental implant failure: a cohort study[J]. Clin Implant Dent Relat Res, 2017,19(2):222-232. DOI: 10.1111/cid.12455.
[41] Su B, O'Connor JP. NSAID therapy effects on healing of bone, tendon, and the enthesis[J]. J Appl Physiol (1985), 2013,115(6):892-899. DOI: 10.1152/japplphysiol.00053.2013.
[42] Corbella S, Morandi P, Alberti A, et al.The effect of the use of proton pump inhibitors, serotonin uptake inhibitors, antihypertensive, and anti-inflammatory drugs on clinical outcomes of functional dental implants: a retrospective study[J]. Clin Oral Implants Res, 2022,33(8):834-843. DOI: 10.1111/clr.13964.
[43] Basson AA, Mann J, Findler M, et al.Correlates of early dental implant failure: a retrospective study[J]. Int J Oral Maxillofac Implants, 2023,38(5):897-906. DOI: 10.11607/jomi.10199.
[44] Romandini M, Lima C, Pedrinaci I, et al.Prevalence and risk/protective indicators of peri-implant diseases: a university-representative cross-sectional study[J]. Clin Oral Implants Res, 2021,32(1):112-122. DOI: 10.1111/clr.13684.
[45] Insua A, Galindo-Moreno P, Miron RJ, et al.Emerging factors affecting peri-implant bone metabolism[J]. Periodontol 2000, 2024,94(1):27-28.DOI: 10.1111/prd.12532.
[46] Kedika RR, Souza RF, Spechler SJ.Potential anti-inflammatory effects of proton pump inhibitors: a review and discussion of the clinical implications[J]. Dig Dis Sci, 2009,54(11):2312-2317. DOI: 10.1007/s10620-009-0951-9.
[47] 樊龙, 罗莉婷. 医院2022年质子泵抑制剂处方点评及不合理处方分析[J].临床合理用药,2023,16(36):149-151, 155. DOI: 10.15887/j.cnki.13-1389/r.2023.36.042.